CDC73 and pachyonychia congenita: FIHP patients with MEN1 and CASR mutations are generally younger and have multiglandular disease, whereas patients with CDC73 mutations have a disproportionally high prevalence of PC (Warner et al., 2004; Iacobone et al., 2007).